Work

P3-087: Phase II trial of sequenced bevacizumab and erlotinib with bevacizumab and chemotherapy for 1st line stage IIIB or IV Non-small cell lung cancer (NSCLC)

Year: 2007

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1097/01.jto.0000284063.57103.13

Authors: Ramaswamy Govindan, Ezra E. Cohen, Mark F. Kozloff, Ann M. Mauer, Philip C. Hoffman, Theodore Karrison, Julie Schwegman, Livia Szeto, Ravi Salgia, Everett E. Vokes

Institutions: Washington University in St. Louis, University of Chicago, Ingalls Memorial Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2034730607

FWCI:

Cites:

Cited by:

Related to: 10